Corrigendum to "Age at onset of schizophrenia: Cannabis, COMT gene, and their interactions" [Volume 151, Issues 1-3, December 2013, Pages 289-290], doi: 10.1016/j.schres.2013.10.037;Age at onset of schizophrenia: Cannabis, COMT gene, and their interactions

Schizophrenia Research

Volumn 151, Issue 1-3, 2013, Pages 289-290

  De Sousa, Kim R ^a   Tiwari, Arun K ^a   Giuffra, Daniel E ^a   Mackenzie, Bronwyn ^a   Zai, Clement C ^a   Kennedy, James L ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE;

CANNABIS ADDICTION; CANNABIS USE; COMT GENE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEALTH EDUCATION; HEREDITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PEER COUNSELING; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; ANALYSIS OF VARIANCE; CATECHOL O-METHYLTRANSFERASE; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEX FACTORS; YOUNG ADULT;

EID: 84889091810     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.09.031     Document Type: Erratum

References (8)

1. Arseneault L., Cannon M., Witton J., Murray R.M. Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry 2004, 184:110-117.
2. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol. Psychiatry 2005, 57:1117-1127.
3. Di Forti M., Iyegbe C., Sallis H., Kolliakou A., Falcone M.A., Paparelli A., Sirianni M., La Cascia C., Stilo S.A., Marques T.R., Handley R., Mondelli V., Dazzan P., Pariante C., David A.S., Morgan C., Powell J., Murray R.M. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol. Psychiatry 2012, 72(10):811-816.
4. Kantrowitz J.T., Nolan K.A., Sen S., Simen A.A., Lachman H.M., Bowers M.B. Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians. Psychiatry Q. 2009, 80:213-218.
5. Meier M.H., Caspi A., Ambler A., Harrington H., Houts R., Keefe R.S., McDonald K., Ward A., Poulton R., Moffitt T.E. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(40). E2657-E2664 (Oct 2).
6. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
7. Pelayo-Teran J.M., Perez-Iglesias R., Mata I., Carrasco-Marin E., Vazquez-Barquero J.L., Crespo-Facorro B. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications. Psychiatry Res. 2010, 179:291-296.
8. Zammit S., Owen M.J., Evans J., Heron J., Lewis G. Cannabis, COMT and psychotic experiences. Br. J. Psychiatry 2011, 199:380-385.